Quantcast
Last updated on April 21, 2014 at 1:20 EDT

Latest Pfizer Canada Inc. Stories

2014-03-03 12:25:02

SOCHI, Russia, March 3, 2014 /CNW/ - With the Sochi 2014 Paralympic Games set to begin in just four days, the Canadian Paralympic Committee would like to celebrate and thank long-time premier partner Pfizer Canada Inc., who have gone above and beyond their sponsorship agreement and made an additional financial contribution to the Canadian Paralympic Team. Pfizer Canada is the CPC's longest standing corporate partner, a relationship that dates back to 1996. "Canada's...

2014-02-07 16:24:13

TORONTO, Feb. 7, 2014 /CNW/ - Pfizer Canada Inc., the Canadian distributor of EpiPen® (epinephrine) Auto Injector is proud to announce its entry in the 2014 NASCAR Canadian Tire Series as the title sponsor of Alex Tagliani's No. 18 car. "Pfizer is pleased to be entering the NASCAR Canadian Tire Series as Alex Tagliani's title sponsor," said Allen Van Der Wee, General Manager, Global Established Products Business Unit at Pfizer Canada Inc. "We are looking forward to partnering...

2013-11-27 08:25:23

Pfizer launches Leaders in Pharmacy initiative to support the evolving role of pharmacists in Canadian healthcare, foster excellence in pharmacist leadership KIRKLAND, QC, Nov. 27, 2013 /CNW/ - A new Canadian survey reveals that while the vast majority of Canadians trust their pharmacist and see them as valued partners in their healthcare, many are not aware of the rapidly expanding roster of healthcare services pharmacists can provide. In response to the growing importance of...

2013-10-16 08:26:42

New survey shows Canadian women still harbour misconceptions about menopause as well as the options available to help alleviate some of the symptoms associated with this transitional life change KIRKLAND, QC, Oct. 16, 2013 /CNW/ - In advance of World Menopause Day (October 18), a new survey conducted by Ipsos Reid on behalf of Pfizer Canada reveals that while many women ages 45-60 are optimistic about keeping their vitality during menopause, about half (46%) of Canadian women in...

2013-07-26 08:25:14

OTTAWA, July 26, 2013 /CNW/ - The Ontario Superior Court has certified a class action for Canadians who took Champix between April 2, 2007 and May 31, 2010 and allegedly suffered certain reactions. The lawsuit seeks compensation and alleges that, between April 2, 2007 and May 31, 2010, Pfizer Canada Inc. failed to adequately warn of the risk of certain psychiatric adverse events allegedly related to Champix. Pfizer Canada Inc. denies the allegations, which have not been...

2013-05-01 12:27:25

TORONTO, May 1, 2013 /CNW/ - Pfizer Canada Inc., the Canadian distributor of EpiPen® (epinephrine auto-injector) is proud to partner with Indy Race Car driver Alex Tagliani in an exciting new initiative to promote food allergy awareness and safety. The Summer of TAG (Treating Allergies with Genuine Care), will support Alex's charity of choice, Anaphylaxis Canada, in their efforts to engage Canadians in a conversation about effective management of food allergies and what to do in the...

2013-02-15 12:22:47

MONTREAL, Feb. 15, 2013 /PRNewswire/ - The Government of Québec announced today a $10 million investment in the Personalized Medicine Partnership for Cancer (PMPC).  This public-private partnership will be focused on establishing an integrated approach for the development and implementation of clinical biomarkers and other personalized healthcare solutions to improve the outcome and cost-efficiency of healthcare services provided to cancer patients in the province of...

2012-11-20 08:26:56

Decision Allows for Broader Access to Vaccine for the Prevention of Pneumococcal Disease in Adults KIRKLAND, QC, Nov. 20, 2012 /CNW/ - Pfizer Canada announced today that the World Health Organization (WHO) has granted an expansion to the prequalification of Pfizer's pneumococcal conjugate vaccine, Prevnar 13, to include immunization of adults 50 years of age and older against pneumonia and invasive disease caused by the 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C,...

2012-06-12 02:25:35

Fifth Annual Awards Competition Dedicated to Independent Pain Research KIRKLAND, QC, June 12, 2012 /CNW/ - Pfizer Canada is pleased to announce the recipients of the 2011 Neuropathic Pain Research Awards, an annual grant competition for independent research in the areas of basic biomedical, clinical and health service and systems sciences.(1) "For the past five years, the Neuropathic Pain Research Awards have supported Canadian medical innovation and research in neuropathic pain,"...

2012-05-30 06:25:10

XALKORI NOW AVAILABLE IN CANADA KIRKLAND, QC, May 30, 2012 /CNW/ - Pfizer Canada is pleased to announce that XALKORI(®) (crizotinib) is now available in Canada. Recently approved with conditions by Health Canada, XALKORI is an oral monotherapy for patients with anaplastic lymphoma kinase (ALK)-positive advanced or metastatic non-small cell lung cancer (NSCLC).(1) XALKORI is Pfizer Canada's first example of personalized medicine for people with ALK-positive non-small cell lung...